Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 13, Issue 1, 2007, Pages 42-50

  Sylvester, Francisco A ^a,b   Wyzga, Nancy ^a,b   Hyams, Jeffrey S ^a,b   Davis, Patricia M ^a,b   Lerer, Trudy ^a,b   Vance, Katherine ^a,b   Hawker, Gillian ^c,d   Griffiths, Anne M ^e  

^a Division of Pediatric Infectious Diseases   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Bone density; Bone formation; Children; Crohn's disease; Ulcerative colitis

Indexed keywords

CALCIUM; CORTICOSTEROID; INTERLEUKIN 6; PARATHYROID HORMONE; PREDNISONE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BLOOD LEVEL; BODY MASS; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CALCIUM INTAKE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOBLAST; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCREENING; ULCERATIVE COLITIS;

ADOLESCENT; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; CALCIUM, DIETARY; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; DENSITOMETRY, X-RAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; OSTEOGENESIS; PARATHYROID HORMONE; VITAMIN D;

EID: 33846142513     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20006     Document Type: Article

References (41)

1. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998;42:188-194.
2. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density, assessment in children with inflammatory bowel disease. Gastroenterology. 1998;114:902-911.
3. Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJ. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology. 2000;119:1203-1208.
4. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med. 2000;247:63-70.
5. Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut. 2000;46:176-181.
6. Loftus EV Jr, Crowson CS, Sandborn WJ, Tremaine WJ, O'Fallon WM, Melton LJ 3rd. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology. 2002;123:468-475.
7. NIH Consensus Development Panel on Osteoporosis Prevention D, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-795.
8. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut. 1997;40:228-233.
9. Schulte C, Dignass AU, Mann K, Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis. 1998;4:268-275.
10. Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology. 2004;127:792-801.
11. Compston JE. Can biochemical markers be used to screen patients with inflammatory bowel disease for Osteoporosis? Eur J Gastroenterol Hepatol. 2002;14:587-589.
12. Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporos Int. 1993;3:236-241.
13. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795-841.
14. Justinich CJ, Hyams JS. Inflammatory bowel disease in children and adolescents. Gastrointest Endosc Clin N Am. 1994;4:39-54.
15. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
16. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;1041-1048.
17. van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM. Reference data for bone density and body composition measured with dual energy × ray absorptiometry in white children and young adults. Arch Dis Child. 2002;87:341-347.
18. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press; 1959.
19. Ellis KJ, Shypailo RJ, Hardin DS, et al. Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res. 2001;16:1658-1664.
20. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004;19:1961-1968.
21. Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr. 2005;135:332-337.
22. Elmlinger MW, Ackermann S, Wollmann HA, Heitz M, Osme A, Ranke B. Significance of bone specific alkaline phosphatase and procollagen-I-peptide as diagnostic markers of bone formation for monitoring growth hormone therapy. In: Congress on Calcium Regulating Hormones and Bone Metabolism. Giessen, Germany; 1995.
23. Issenman RM, Atkinson SA, Radoja C, Fraher L. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn's diesease. J Pediatr Gastroenterol Nutr 1993;17:401-6.
24. Semeao EJ, Jawad AF, Stallings VA, Piccoli DA. Effect of site of disease and steroid exposure on bone mineral density (BMD) in children with Crohn's disease. J Pediatr Gastroenterol Nutr. 1997;25:451.
25. Gupta A, Paski S, Issenman R, Webber C. Lumbar spine bone mineral density at diagnosis and during follow-up in children with IBD. J Clin Densitom. 2004;7:290-295.
26. Herzog D, Bishop N, Glorieux F, Seidman EG. Interpretation of bone mineral density values in pediatric Crohn's disease. Inflamm Bowel Dis. 1998;4:261-267.
27. Ahmed SF, Horrocks IA, Patterson T, et al. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J Pediatr Gastroenterol Nutr. 2004;38:276-280.
28. Gafni RI, Baron J. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr. 2004;144:253-257.
29. Stains JP, Civitelli R. Cell-to-cell interactions in bone. Biochem Biophys Res Commun. 2005;328:721-727.
30. Lin CL, Moniz C, Chambers TJ, Chow JW. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology. 1996;111:1263-1271.
31. Hyams JS, Wyzga N, Kreutzer DL, Justinich CJ, Gronowicz GA. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr. 1997;24:289-295.
32. Varghese S, Wyzga N, Griffiths AM, Sylvester FA. Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr. 2002;35:641-648.
33. Sentongo TA, Semaeo EJ, Stettler N, Piccoli DA, Stallings VA, Zemel BS. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002;76:1077-1081.
34. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem. 2006;52:1120-1126.
35. Driscoll RH Jr, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology. 1982;83:1252-1258.
36. Crabtree NJ, Kibirige MS, Fordham JN, et al. The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone. 2004;35:965-972.
37. Rauch F, Bailey DA, Baxter-Jones A, Mirwald R, Faulkner R. The 'muscle-bone unit' during the pubertal growth spurt. Bone. 2004;34:771-775.
38. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL. Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology. 1993;104:1285-1292.
39. Semeao EJ, Stallings VA, Peck SN, Piccoli DA. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology. 1997;112:1710-1713.
40. Stockbrugger RW, Schoon EJ, Bollani S, et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther. 2002;16:1519-1527.
41. Klaus J, Armbrecht G, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut. 2002;51:654-658.